TheProfitWatch

NKTR - Nektar Therapeutics

Day 1m 10m 60m PreMarket Market AfterHours Gap
58.89 -1.99 (-3.38%) --- 0.3 (0.53%) 0.01 (0.02%) -1.28 (-2.17%) -1.11 (-1.91%) 0.01 (0.02%) 0.01 (0.02%)

Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-2.95
Diluted EPS:
-2.95
Basic P/E:
-19.2881
Diluted P/E:
-19.2881
RSI(14) 1m:
50.85
VWAP:
56.9
RVol:

Events

Period Kind Movement Occurred At

Related News